EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker

Hao Chen, Yizhou Xu

Heart and Vessels · 05.04.2026

DOI: 10.1007/s00380-026-02681-4 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Heart and Vessels, online erschienen am 05.04.2026. Verfasst von Hao Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310000, China. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310000, China.
  • Department of Cardiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310000, China.
  • Department of Cardiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310000, China. xyzhzsyxnk@163.com.

Zitieren

APA

Chen, H., & Xu, Y. (2026). Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker. Heart and Vessels. https://doi.org/10.1007/s00380-026-02681-4

Vancouver

Chen H, Xu Y. Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker. Heart and Vessels. 2026. doi:10.1007/s00380-026-02681-4

BibTeX
@article{Chen2026,
  author = {Chen, Hao and Xu, Yizhou},
  title = {Serum albumin in cancer survivors with heart failure: beyond a static prognostic marker},
  journal = {Heart and Vessels},
  year = {2026},
  doi = {10.1007/s00380-026-02681-4}
}
Kostenlos starten →